Published online Nov 6, 2023. doi: 10.12998/wjcc.v11.i31.7690
Peer-review started: August 30, 2023
First decision: September 20, 2023
Revised: October 6, 2023
Accepted: October 26, 2023
Article in press: October 26, 2023
Published online: November 6, 2023
Processing time: 67 Days and 20.5 Hours
Renal pelvis sarcomatoid carcinoma (RPSC) is a rare and aggressive malignancy whose diagnosis is difficult because radiological imaging results can lead to misclassification as a more common type of renal tumor. In addition, clinical management of patients with RPSC is difficult because of the limited efficacy of available treatments. In this study, we present a comprehensive description of a patient who presented with RPSC and a simultaneous renal vein tumor thrombus.
During April, 2020, a 64-year-old female presented with an isolated episode of hematuria accompanied by abdominal pain. Computed tomography (CT) and magnetic resonance imaging (MRI) showed a lesion in the right renal pelvis. We therefore performed a radical nephrectomy of the right kidney. The subsequent histopathological and immunological results verified the diagnosis of RPSC. Despite administration of 6 cycles of a gemcitabine-cisplatin regimen, the patient's condition progressively deteriorated, and she died about 15 mo after the ne
We performed a comprehensive analysis of a patient with RPSC that included CT, MRI, immunohistochemistry, and genetic testing. The insights from our detailed analysis of this patient and our concomitant review of the literature may assist clinicians in their diagnosis and treatment of RPSC.
Core Tip: Renal pelvis sarcomatoid carcinoma (RPSC) is an extremely rare tumor that is associated with a high mortality rate. We present a rare case of right RPSC with renal vein tumor thrombus, in which diagnosis was based on evidence from radiology, pathology, and analysis of tumor mutations. The specific genetic mutations in this patient’s tumor may provide insights into the invasive phenotype and pathogenesis of this cancer.